DE RIZ, MILENA ALESSANDRA
DE RIZ, MILENA ALESSANDRA
Universita' degli Studi di MILANO
Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian M sclerosis and related disorders register
2022 R. Bergamaschi, E. Beghi, C. Bosetti, M. Ponzio, C. Santucci, V. Lepore, P. Mosconi, U. Aguglia, M.P. Amato, A.L. Ancona, B. Ardito, C. Avolio, R. Balgera, P. Banfi, V. Barcella, P. Barone, P. Bellantonio, A. Berardinelli, R. Bergamaschi, P. Bertora, M. Bianchi, P. Bramanti, V.B. Morra, G. Brichetto, A.M. Brioschi, M. Buccafusca, S. Bucello, V. Busillo, B. Calchetti, R. Cantello, M. Capobianco, F. Capone, L. Capone, D. Cargnelutti, M. Carrozzi, E. Cartechini, G. Cavaletti, P. Cavalla, M.G. Celani, R. Clerici, M. Clerico, E. Cocco, P. Confalonieri, M.G. Coniglio, A. Conte, F. Corea, S. Cottone, P. Crociani, F. D'Andrea, M.C. Danni, G. De Luca, D. de Pascalis, M. De Riz, F. De Robertis, G. De Rosa, N. De Stefano, M.D. Corte, A. Di Sapio, R. Docimo, M. Falcini, N. Falcone, S. Fermi, E. Ferraro, M.T. Ferrò, M. Fortunato, M. Foschi, A. Gajofatto, A. Gallo, P. Gallo, M. Gatto, P. Gazzola, A. Giordano, F. Granella, M.F. Grasso, M.G. Grasso, L.M.E. Grimaldi, P. Iaffaldano, D. Imperiale, M. Inglese, R. Iodice, S. Leva, V. Luezzi, A. Lugaresi, G. Lus, D. Maimone, L. Mancinelli, G.T. Maniscalco, G.A. Marfia, B. Marini, A. Marson, N. Mascoli, L. Massacesi, F. Melani, M. Merello, G. Meucci, M. Mirabella, S. Montepietra, D. Nasuelli, P. Nicolao, F. Passantino, F. Patti, M. Peresson, I. Pesci, C. Piantadosi, M.L. Piras, M. Pizzorno, K. Plewnia, C. Pozzilli, A. Protti, R. Quatrale, S. Realmuto, G. Ribizzi, S. Rinalduzzi, A. Rini, S. Romano, M. Romeo, M. Ronzoni, P. Rossi, M. Rovaris, G. Salemi, G. Santangelo, M. Santangelo, G. Santuccio, P. Sarchielli, L. Sinisi, P. Sola, C. Solaro, D. Spitaleri, S. Strumia, T. Tassinari, S. Tonietti, C. Tortorella, R. Totaro, A. Tozzo, G. Trivelli, M. Ulivelli, P. Valentino, S. Venturi, M. Vianello, M. Zaffaroni, R. Zarbo, M. Trojano, M.A. Battaglia, M. Capobianco, M. Pugliatti, M. Ulivelli, P. Mosconi, C. Gasperini, F. Patti, M.P. Amato, G. Comi
Role of Chitinase 3-like 1 as a Biomarker in Multiple Sclerosis: A Systematic Review and Meta-analysis
2022 S. Floro, T. Carandini, A.M. Pietroboni, M.A. De Riz, E. Scarpini, D. Galimberti
miR-150-5p and let-7b-5p in Blood Myeloid Extracellular Vesicles Track Cognitive Symptoms in Patients with Multiple Sclerosis
2022 F. Scaroni, C. Visconte, M. Serpente, M.T. Golia, M. Gabrielli, M. Huiskamp, H.E. Hulst, T. Carandini, M. De Riz, A. Pietroboni, E. Rotondo, E. Scarpini, D. Galimberti, C.E. Teunissen, M. van Dam, B.A. de Jong, C. Fenoglio, C. Verderio
Slowly expanding lesions relate to persisting black-holes and clinical outcomes in relapse-onset multiple sclerosis
2022 A. Calvi, C. Tur, D. Chard, J. Stutters, O. Ciccarelli, R. Cortese, M. Battaglini, A. Pietroboni, M. De Riz, D. Galimberti, E. Scarpini, N. De Stefano, F. Prados, F. Barkhof
Detection of the SQSTM1 Mutation in a Patient with Early-Onset Hippocampal Amnestic Syndrome
2021 T. Carandini, L. Sacchi, L. Ghezzi, A.M. Pietroboni, C. Fenoglio, A. Arighi, G.G. Fumagalli, M.A. De Riz, M. Serpente, E. Rotondo, E. Scarpini, D. Galimberti
Alemtuzumab in multiple sclerosis during the COVID-19 pandemic: A mild uncomplicated infection despite intense immunosuppression
2020 T. Carandini, A.M. Pietroboni, L. Sacchi, M.A. De Riz, M. Pozzato, A. Arighi, G.G. Fumagalli, F. Martinelli Boneschi, D. Galimberti, E. Scarpini
Evidence of retinal anterograde neurodegeneration in the very early stages of multiple sclerosis: a longitudinal OCT study
2020 A.M. Pietroboni, T. Carandini, L. Dell'Arti, F. Bovis, A. Colombi, M.A. De Riz, E. Casazza, E. Scola, C. Fenoglio, A. Arighi, G.G. Fumagalli, F. Triulzi, D. Galimberti, F. Viola, E. Scarpini
Low CSF β-amyloid levels predict early regional grey matter atrophy in multiple sclerosis [Low CSF beta-amyloid levels predict early regional grey matter atrophy in multiple sclerosis]
2020 A.M. Pietroboni, A. Colombi, T. Carandini, V.E. Contarino, L. Ghezzi, G.G. Fumagalli, A. Arighi, C. Fenoglio, M.A. De Riz, F. Triulzi, E. Scarpini, D. Galimberti
CSF β-amyloid predicts early cerebellar atrophy and is associated with a poor prognosis in multiple sclerosis
2020 A.M. Pietroboni, F. Schiano di Cola, A. Colombi, T. Carandini, C. Fenoglio, L. Ghezzi, M.A. De Riz, F. Triulzi, E. Scarpini, A. Padovani, D. Galimberti
Cerebrospinal Fluid Level of Aquaporin4: A New Window on Glymphatic System Involvement in Neurodegenerative Disease?
2019 A. Arighi, A. Di Cristofori, C. Fenoglio, S. Borsa, M. D'Anca, G.G. Fumagalli, M. Locatelli, G. Carrabba, A.M. Pietroboni, L. Ghezzi, T. Carandini, A. Colombi, M. Scarioni, M.A. De Riz, M. Serpente, P.M. Rampini, E. Scarpini, D. Galimberti
Testing the 2018 NIA-AA research framework in a retrospective large cohort of patients with cognitive impairment: From biological biomarkers to clinical syndromes
2019 T. Carandini, ARIGHI ANDREA, L. Sacchi, FUMAGALLI GIORGIO GIULIO, PIETROBONI ANNA MARGHERITA, L. Ghezzi, COLOMBI ANNALISA, SCARIONI MARTA, C. Fenoglio, DE RIZ MILENA ALESSANDRA, G. Marotta, E. Scarpini, GALIMBERTI DANIELA
Inflammatory expression profile in peripheral blood mononuclear cells from patients with Nasu-Hakola Disease
2019 D. Galimberti, C. Fenoglio, L. Ghezzi, M. Serpente, M. Arcaro, M. D'Anca, M. De Riz, A. Arighi, G.G. Fumagalli, A.M. Pietroboni, L. Piccio, E. Scarpini
Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis : correlation with CSF β-amyloid levels and brain volumes
2019 A.M. Pietroboni, T. Carandini, A. Colombi, M. Mercurio, L. Ghezzi, G. Giulietti, M. Scarioni, A. Arighi, C. Fenoglio, M.A. De Riz, G.G. Fumagalli, P. Basilico, M. Serpente, M. Bozzali, E. Scarpini, D. Galimberti, G. Marotta
The loss of macular ganglion cells begins from the early stages of disease and correlates with brain atrophy in multiple sclerosis patients
2019 A.M. Pietroboni, L. Dell'Arti, M. Caprioli, M. Scarioni, T. Carandini, A. Arighi, L. Ghezzi, G.G. Fumagalli, M.A. De Riz, P. Basilico, A. Colombi, E. Benatti, F. Triulzi, E. Scarpini, F. Viola, D. Galimberti
CSF β-amyloid predicts prognosis in patients with multiple sclerosis
2019 A.M. Pietroboni, M. Caprioli, T. Carandini, M. Scarioni, L. Ghezzi, A. Arighi, S. Cioffi, C. Cinnante, C. Fenoglio, E. Oldoni, M.A. De Riz, P. Basilico, G.G. Fumagalli, A. Colombi, G. Giulietti, L. Serra, F. Triulzi, M. Bozzali, E. Scarpini, D. Galimberti
CSF β-amyloid and white matter damage: A new perspective on Alzheimer's disease
2018 A.M. Pietroboni, M. Scarioni, T. Carandini, P. Basilico, M. Cadioli, G. Giulietti, A. Arighi, M. Caprioli, L. Serra, C. Sina, C. Fenoglio, L. Ghezzi, G.G. Fumagalli, M.A. De Riz, A. Calvi, F. Triulzi, M. Bozzali, E. Scarpini, D. Galimberti
Word and Picture Version of the Free and Cued Selective Reminding Test (FCSRT): Is There Any Difference?
2018 A. Arighi, T. Carandini, M. Mercurio, G. Carpani, A. Pietroboni, G. Fumagalli, L. Ghezzi, P. Basilico, A. Calvi, M. Scarioni, M. De Riz, C. Fenoglio, E. Scola, F. Triulzi, D. Galimberti, E. Scarpini, L. Ghezzi
Evidence of CNS β-amyloid deposition in Nasu-Hakola disease due to the TREM2 Q33X mutation
2017 L. Ghezzi, T. Carandini, A. Arighi, C. Fenoglio, M. Arcaro, M. De Riz, A.M. Pietroboni, G.G. Fumagalli, P. Basilico, A. Calvi, M. Scarioni, A. Colombi, M. Serpente, G. Marotta, R. Benti, E. Scarpini, D. Galimberti
CSF β-amyloid as a putative biomarker of disease progression in multiple sclerosis
2017 A.M. Pietroboni, F. Schiano Di Cola, M. Scarioni, C. Fenoglio, B. Spanò, A. Arighi, S.M.G. Cioffi, E. Oldoni, M.A. De Riz, P. Basilico, A. Calvi, G.G. Fumagalli, F.M. Triulzi, D. Galimberti, M. Bozzali, E.A. Scarpini
Merkel cell carcinoma in a patient with relapsing-remitting multiple sclerosis treated with fingolimod
2017 A. Calvi, M. De Riz, E. Lecchi, A. Pietroboni, L. Ghezzi, M. Scarioni, T. Carandini, A. Pellegrinelli, A. Maurichi, D. Galimberti, E. Scarpini